Get Quote

Marina Biotech (NASDAQOTH:MRNA)

CAPS Game Rating: 1 out of 5

A pharmaceutical company, which is focusing on development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology for delivering both small and large molecule drugs.

Recs

0
Member Avatar pgueudet (< 20) Submitted: 09/11/2007 10:52:02 : Underperform Start Price: $254.00 MRNA Score: +119.09

No product on the market, No partner

Report this Post Reply

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.